Safety and Efficacy of SCT200 in Head and Neck Squamous Cell Carcinoma

Condition:   Head and Neck Cancer Intervention:   Drug: Anti-EGFR monoclonal antibody Sponsors:   Sinocelltech Ltd.;   Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials